Leica Biosystems Imaging, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Leica Biosystems Imaging, Inc.
- Regulatory records
- 2
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name Leica Biosystems Imaging, Inc.. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Aug 7, 2026 to Aug 7, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code PSY appears in 1 of the 2 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 1360 Park Center Dr., Vista, CA, 92081, US. Recorded on K253561, decision dated Aug 7, 2026.
Device categories in this collection
Digital Pathology Image Artifact Detection Software Device; Whole Slide Imaging System.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Aperio iQC DX Software
K253561 · 510(k) clearanceAperio GT 450 DX; Aperio GT 180 DX
K253554 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.